CD9 and stroke disorder: In the current study we sought to assess levels of double-stained vesicles (CD171 + CD9 +, EAAT1 + CD9 +, and MOG + CD9 +), hereafter referred to as NDEs, ADEs, and oligodendrocyte-derived EVs (ODEs) respectively, over the first month post-stroke.